Auxly and Kindred Announce Canadian Brokerage Agreement
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly") and Kindred Partners Inc. ("Kindred") are pleased to announce that they have entered into a brokerage agreement pursuant to which Kindred will act as Auxly's exclusive sales agent for its adult-use cannabis products in Canada.
E-Commerce is Steadily Becoming a Viable Platform for the Cannabis Industry
Over the past several decades, the retail industry has drastically changed due to the development and propagation of e-commerce. Today, many consumers tend to prefer purchasing products online because they can simply browse stores anywhere at the palm of their hands. However, transitioning towards a digital business is not as simple as it seems for certain industries. Specifically, the cannabis industry has faced countless legal barriers that have hindered its expansion into the digital marketplace. For instance, because of cannabis' legality concern, companies in industries like finance, marketing, and advertising have steered clear. However, as more regions continue to move towards legalization, various industries have become interested in locking into agreements and partnerships with cannabis companies. In particular, the U.S. passed the Farm Bill in 2018, which legalized hemp-derived CBD products. Initially, many companies explicitly noted that they wouldn't partake in the cannabis industry because of legal concerns. Nonetheless, after the passage of the Farm Bill, large corporations had begun to commercialize and advertise CBD products. And as the cannabis industry continues to expand, it is expected that technology will play a pivotal role in the development of the industry. While brick-and-mortar dispensaries will still be popular in legal regions, digital platforms are projected to further accelerate overall sales. According to data compiled by Ameri Research, the global legal marijuana market was valued at USD 14.3 Billion in 2016. By 2024, legal marijuana global sales are projected to reach USD 63.5 Billion while exhibiting a CAGR of 21.1% from 2017 to 2024. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), KushCo Holdings, Inc. (OTC: KSHB), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX: TGOD), MariMed Inc. (OTC: MRMD), Auxly Cannabis Group Inc. (OTC: CBWTF) (TSX-V: XLY)
Technology Aides the Cannabis Industry to Overcome Regulatory Obstacles
Cannabis legalization efforts are rapidly accelerating, yet under federal regulations, the plant is still classified as an illegal substance. Currently, more than half the U.S. has legalized cannabis for either medical or recreational use. The classification of plant puts the cannabis industry in a difficult position. For instance, many banks explicitly mention they will not provide financial services such as loans or opening an account for a cannabis-related business. Shannon Hatton, Co-Founder and Chief Executive Officer of Fiddler's Greens, a California-based tincture maker, said she experienced numerous issues with starting up her business because bank loans were not an option. If Hatton were to mention cannabis when applying for a loan, she could potentially run the risk of having her checking account closed, according to Leafly. Henceforth, creating a cannabis business is not a simple task and requires a large sum of money. For example, opening a legal adult-use business can cost anywhere from USD 2 Million to USD 5 Million. Additionally, businesses can also wait up to two years before they are approved for a license to operate. And for anyone attempting to start a business, the metrics could be very intimidating. As a result, entrepreneurs have seized the opportunity and created their own institutions to serve the cannabis industry. According to Mordor Intelligence, the cannabis market is expected to reach USD 89.1 Billion from USD 14.5 Billion in 2018. Additionally, the market is expected to register a CAGR of 37% during the forecast period from 2019 to 2024. Global Payout, Inc. (OTC: GOHE), The Supreme Cannabis Company, Inc. (OTC: SPRWF) (TSX: FIRE), Auxly Cannabis Group Inc. (OTC: CBWTF) (TSX-V: XLY), Liberty Health Sciences Inc. (OTC: LHSIF) (CSE: LHS), United Cannabis Corporation (OTC: CNAB)
Auxly Announces Signing Of Term Sheet For $84 Million Credit Facilities Through Its Joint Venture Partner, Sunens Farms Inc.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that its joint venture partner, Sunens Farms Inc. ("Sunens"), has entered into a term sheet for a syndicated credit facility, with the Bank of Montreal ("BMO") as Lead Underwriter and, subject to the satisfaction of certain customary closing conditions and the finalization of definitive loan documentation, expects to receive debt financing in the aggregate amount of approximately $84 million. The syndicated senior debt facility will be for $71.5 million (the "Credit Facility") for a three-year term together with a BMO $12.5 million leasing facility (the "Leasing Facility").
Savvy Investors Seek out Innovative Cannabis Opportunities
The booming cannabis industry has created opportunities for many driven entrepreneurs. In particular, many may be looking to launch something standard such as operating a retail dispensary or starting up a cultivation facility. However, these are the most common businesses within the cannabis industry and face heavy competition among one another. Moreover, dispensaries and cultivation sites both require licenses granted from the federal or provincial governments and some regions can experience a large influx of applications while typically, only a handful are granted to companies. While certain businesses can dominate a region or report attractive financials, investors are more interested in innovative companies and in 2018, they poured approximately USD 1.3 Billion into startups and other private ventures, according to Crunchbase. Overall, investors are keen on the cannabis startup market space as a multitude of companies have developed innovative ways to consume or grow cannabis. Furthermore, the statistics do not include all investments made. For instance, tobacco giant, Altria, and beverage producer, Constellation Brands, poured billions of dollars collectively into the industry. To note, the two large corporations invested in the industry because they are witnessing their primary market segment growth decline.in addition to the largest names in the cannabis market, there are plenty of small companies that are creating extraordinary products or technologies to help accelerate the growth of the industry. Overall, the cannabis industry is still in its infancy stage, meaning there is still a plethora of opportunities to seize. According to data compiled by Grand View Research, the global legal marijuana market is expected to reach USD 146.4 Billion by 2025 while registering a CAGR of 34.6%. Codebase Ventures Inc. (OTC: BKLLF) (CSE: CODE), India Globalization Capital, Inc. (NYSE-A: IGC), Auxly Cannabis Group Inc. (OTC: CBWTF) (TSX-V: XLY), United Cannabis Corporation (OTC: CNAB), Invictus MD Strategies Corp. (OTC: IVITF) (TSX-V: GENE)
Auxly Welcomes $123 Million Investment and R&D Partnership with Imperial Brands
-- Imperial Brands to invest approximately $123 million by way of a debenture convertible into 19.9% ownership of Auxly at a conversion price of $0.81 per share
The Most Important Cannabis Trends of 2019
Not too long ago, cannabis was just the feel-good supplement of choice for a young generation, looking to blow off steam. But intense research on the plant has led to new discoveries. Today, cannabis is used not only to blow off some steam, but to treat diseases which effect the immune system, pain and inflammation, seizures and even mental disorders. Mentioned in today's commentary includes: Supreme Cannabis (OTCQX:SPRWF) (TSX:FIRE), Auxly Cannabis (OTCQX:CBWTF) (TSX-V:XLY), Constellation Brands (NYSE:STZ), Emerald Health Therapuetics (OTCQX:EMHTF) (TSX-V:EMH), MedMen Enterprises (OTCQX:MMNFF) (CSE:MMEN).
Horizons ETFs Rebalances Marijuana-Focused ETFs
TORONTO , July 3, 2019 /CNW/ - Horizons ETFs Management ( Canada ) Inc. (" Horizons ETFs ") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (" HMMJ " :TSX ), the Horizons US Marijuana Index ETF (" HMUS " :NEO ) and the Horizons Emerging Marijuana Growers Index ETF (" HMJR " :NEO ).
Inventive New Technologies Have the Potential to Reshape the Cannabis Industry
Technology has become a major growth factor for nearly every major industry around the globe. The advancements within the tech industry have allowed companies in various sectors to simplify their business operations while delivering optimal service. One industry of notice that has benefited from the rapid evolution of technology is the cannabis market. Entrepreneurs and investors are eager to introduce the idea of technologies such as blockchain into the industry. For instance, there are many different types of tech already within the industry such as tracking and verification systems. Specifically, tracking and verification platforms allow users and business operators to track the product from seed-to-sale, and the information provided will allow consumers to understand where their product originated from as well as its growing process. Furthermore, verification platforms also enable consumers to validate the efficacy and legitimacy of the product they purchase. And while counterfeit products and understanding may be a concern within the cannabis marketplace, companies have developed technological platforms in order to help educate consumers. Furthermore, as the industry continues to grow, innovators are working to develop new, state-of-the-art technology to completely reshape the scene. According to The Verge, claims of "machine learning" and "automation" are becoming popular within the cannabis industry. For example, a Massachusetts-based company, Bloom Automation, has developed a robot that can automate the cannabis trimming process, eliminating the need for humans. The technological advancements ongoing within the cannabis marketspace are expected to accelerate the industry and provide safer and cleaner products for consumers. According to data compiled by Verified Market Research, the global marijuana market was valued at USD 42.20 Billion in 2016. By 2025, the market is expected to reach USD 466.81 Billion while registering a CAGR of 35.3% from 2018 to 2025. AREV Brands International Ltd. (OTC: AREVF) (CSE: AREV), iAnthus Capital Holdings, Inc. (OTC: ITHUF) (CSE: IAN), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), Planet 13 Holdings Inc. (OTC: PLNHF) (CSE: PLTH), Auxly Cannabis Group Inc. (OTC: CBWTF) (TSX-V: XLY)
Studies Add Validity to Cannabis' Medical Capabilities
All over the world, the debate over cannabis' ability to replace traditional medicines goes on as more medicinal applications continue to emerge. A handful of countries have already adopted medical cannabis programs due to the positive results of multiple extensive studies, while others, however, still remain on the fence. Nevertheless, countries such as Australia, Canada, France, Germany, and large swathes of the U.S. have already implemented medicinal cannabis legislation. According to Healthline, marijuana, a derivative of the cannabis plant, has been used to treat chronic pain as far back as 2900 B.C. However, international government bodies classified cannabis and its derivatives as a narcotic due to the psychoactive effects caused by its THC compound. In order to overturn the classification, medical institutions and researchers have begun conducting clinical trials to evaluate the efficacy of the plant and its chemical components. Now, scientists have discovered that certain components of the cannabis plant, such as CBD and THC, are heavily linked to the successful treatment of a variety of medical conditions. The human body contains a biological system dubbed the endocannabinoid system which is connected to biological functions such as sleep, appetite, pain, and the immune system response. The human body naturally produces these endocannabinoids, which are neurotransmitters that bind to cannabinoid receptors in the nervous system. As a result, studies have shown that cannabinoids can effectively suppress pain, stimulate appetite, or alleviate depression. Currently, the medical cannabis sector accounts for the majority of the global cannabis market because of its widespread adoption. However, researchers have suggested that a larger shift from medical to recreational cannabis is expected to occur as countries like Canada and the U.S. ramp up their adult-use programs. Nonetheless, despite the ongoing development within the recreational market, medical cannabis will continue to be more readily available and accessible to consumers around the globe. According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 14.5 Billion in 2018. By 2024, the market is projected to reach USD 89.1 Billion while exhibiting a CAGR of 37% during the forecast period from 2019 to 2024. Trutrace Technologies Inc. (OTC: BKKSF) (TSX-V: TTT), India Globalization Capital, Inc. (NYSE-A: IGC), Auxly Cannabis Group Inc. (OTC: CBWTF) (TSX-V: XLY), InMed Pharmaceuticals, Inc. (OTC: IMLFF) (TSX: IN), Invictus MD Strategies Corp. (OTC: IVITF) (TSX-V: GENE)